Inherently
propelled by a stringent regulatory framework, antidiabetics
market is strongly characterized by the legalized norms implemented by
authorized bodies such as the European CE and the FDA. Having undertaken the
crucial responsibility of regulating the commercialization of antidiabetics in
clinical trials, these organizations continue to strive hard to approve drugs
post their testing with utmost caution and precision, which is a prime factor
driving the growth of antidiabetics industry. For instance, recently, the U.S.
Food and Drug Administration approved the Bydureon BCise (exenatide
extended-release) injectable suspension manufactured by AstraZeneca.
Apparently,
this drug is an all-new formulation of Bydureon that is available as a
single-dose autoinjector device for adults suffering from Type II diabetes. The
Bydureon BCise apparently underwent two clinical trials prior to obtaining the
approval, thus validating the fact that antidiabetics market outlook is
strictly defined by a regulatory frame of reference.
With
the exponentially growing population and the prevalence of a sedentary
lifestyle, a significant rise in the patient pool suffering from diabetes has
been observed, which is likely to spur global antidiabetics market share. The
WHO estimates that diabetes would be among the leading causes of death by 2030,
which would severely strain the overall healthcare fraternity. The rising
number of diabetic cases have prompted the governments across various
geographies to take steps toward promoting awareness regarding this disorder.
For instance, the ‘Diabetes UK’ is slated to launch one of the biggest
campaigns to encourage consciousness regarding Type II diabetes.
The
program will also make people aware of the harmful consequences of developing
diabetes, encourage them to get screened regularly, and provide other related
details. The prevalence of campaigns and awareness programs such as the
aforementioned are certain to bring about a positive influence on antidiabetics
market size, which was pegged at USD 49.5 billion in 2016.
Browse key industry insights spread across 130 pages with 55 market data tables & 8 figures & charts
from the report Antidiabetics Market
in
detail along with the table of contents:
In
consequence to the unmet medical requirements of the healthcare fraternity and
the rapid increase in the diabetic patient base, antidiabetics industry players
have been concentrating on increasing their funding on research &
development activities with an aim to launch novel insulin products that will
efficiently treat this persistent sugar disorder. Major companies such as
Sanofi Aventis, Eli Lilly, and Novo Nordisk presently predominate antidiabetic
market share, pertaining to their popular brand value, wide range of products,
and increased R&D investments. Many antidiabetics products that are
currently in the pipeline to be commercialized are manufactured by these companies.
In addition, global antidiabetics industry involves the participation of other
generic manufacturers such as Pfizer, Oramed Pharmaceuticals, Inc., Takeda
Pharmaceuticals, Boehringer Ingelheim, and Merck & Co. Inc.
An insight into APAC
antidiabetics market trends:
The
Asia Pacific region has been forecast to emerge as the potential hotbed for
investors emptying their coffers in antidiabetics industry. This estimation may
be attributed to the fact that the region has been witnessing a tremendous
surge in the patient pool suffering from diabetes, especially in India and
China. As per reliable statistics, close to nearly two decades earlier, in
2000, India stood at the top of the pyramid representing diabetes sufferers,
with more than 31.7 million of its populace afflicted by the disease, while
China stood at the second place with 20.8 million diabetic patients in tow. It
has been forecast that by 2030, this number would increase up to 79.4 million
patients in India and 42.3 million individuals in China. The estimates stand to
validate that these countries would prove to be lucrative grounds for companies
partaking in antidiabetics market share, as they would be able to bring forth a
range of medications for treating the affliction in these regions.
Another
emerging region in this continent has been touted to be Japan. The country,
with its incredible healthcare infrastructure, rising penetration of
technologically innovative insulin drugs, and the growing prevalence of
diabetes among the geriatric populace, will serve to be a profitable growth
avenue for APAC antidiabetics market.
Regulatory
and governmental bodies across the globe have been striving to increase public
awareness regarding diabetes, which most certainly would provide an impetus to
antidiabetics market. For instance, the National Institute of Diabetes and
Digestive and Kidney Diseases has undertaken several education campaigns such
as ‘Small Steps, Big Rewards’, ‘Control your Diabetes for Life’, etc., to
increase the importance of diabetic screening, diagnosis, and treatment. Not
far behind in the list of organizations is the American Diabetes Association,
that has also launched several awareness programs regarding diabetes, which
would help carve out a lucrative growth path for global antidiabetics market
over the years ahead. In addition, the International Diabetes Federation, along
with its member associations celebrate the 14th of November as ‘World Diabetes
Day’, utilizing the 24-hour span to initiate awareness campaigns and other
related programs. With a strong regulatory framework and governmental support
in place, not to mention, the pivotal developments underlining the medical
research and healthcare verticals, it is forecast that antidiabetics industry
will chart a profitable growth curve over the coming seven years, with an
estimated valuation of USD 110 billion by 2024.
Precision
Medicine Market Size By Technology (Big Data Analytics, Gene Sequencing,
Drug Discovery, Bioinformatics, Companion Diagnostics), By Application
(Oncology, CNS, Immunology, Respiratory), Industry Analysis Report, Regional
Outlook (U.S., Canada, Germany, UK, France, Scandinavia, Italy, Japan, China,
India, Singapore, Mexico, Brazil, South Africa, UAE, Qatar, Saudi Arabia),
Application Potential, Price Trends, Competitive Market Share & Forecast,
2016 – 2023
About Global Market Insights:
Global Market
Insights, Inc., headquartered in Delaware, U.S., is a global market research
and consulting service provider; offering syndicated and custom research
reports along with growth consulting services. Our business intelligence and
industry research reports offer clients with penetrative insights and actionable
market data specially designed and presented to aid strategic decision making.
These exhaustive reports are designed via a proprietary research methodology
and are available for key industries such as chemicals, advanced materials,
technology, renewable energy and biotechnology.
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter
No comments:
Post a Comment